Literature DB >> 23790726

Absolute risks rather than incidence rates should be used to estimate the number needed to treat from time-to-event data.

Ralf Bender1, Mandy Kromp, Corinna Kiefer, Sibylle Sturtz.   

Abstract

BACKGROUND: When estimating the number needed to treat (NNT) from randomized controlled trials (RCTs) with time-to-event outcomes, varying follow-up times have to be considered. Two methods have been proposed, namely (1) inverting risk differences estimated by survival time methods (RD approach) and (2) inverting incidence differences (ID approach). STUDY DESIGN AND
SETTING: A simulation study was conducted to compare the RD and the ID approaches regarding bias and coverage probability (CP) considering various distributions, baseline risks, effect sizes, and sample sizes. Additionally, the two approaches were compared by using two real data examples.
RESULTS: The RD approach showed good estimation and coverage properties with only a few exceptions in the case of small sample sizes and small effect sizes. The ID approach showed considerable bias and low CPs in most of the considered data situations.
CONCLUSIONS: Absolute risks estimated by means of survival time methods rather than incidence rates should be used to estimate NNTs in RCTs with time-to-event outcomes.
Copyright © 2013 Elsevier Inc. All rights reserved.

Keywords:  Incidence rate; Kaplan–Meier curve; Number needed to treat; Randomized controlled trials; Simulation; Time-to-event data

Mesh:

Year:  2013        PMID: 23790726     DOI: 10.1016/j.jclinepi.2013.01.011

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  3 in total

1.  Rosuvastatin for the prevention of venous thromboembolism: a pooled analysis of the HOPE-3 and JUPITER randomized controlled trials.

Authors:  Philip Joseph; Robert Glynn; Eva Lonn; Chinthanie Ramasundarahettige; John Eikelboom; Jean MacFadyen; Paul Ridker; Salim Yusuf
Journal:  Cardiovasc Res       Date:  2022-02-21       Impact factor: 10.787

2.  Number needed to treat (NNT) in clinical literature: an appraisal.

Authors:  Diogo Mendes; Carlos Alves; Francisco Batel-Marques
Journal:  BMC Med       Date:  2017-06-01       Impact factor: 8.775

3.  Effectiveness of blood pressure-lowering drug treatment by levels of absolute risk: post hoc analysis of the Australian National Blood Pressure Study.

Authors:  Chau Le Bao Ho; Monique Breslin; Jenny Doust; Christopher M Reid; Mark R Nelson
Journal:  BMJ Open       Date:  2018-03-19       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.